Best Life Science Tools & Services Stocks to Buy Now in 2022

The life sciences industry covers many areas, from diagnostics and research to health care services. With such a wide range of sub-sectors, you may be wondering which stocks can give you the best return on investment in the years to come. After all, some firms will perform better than others under different macroeconomic conditions. Therefore, investors should look for stocks that provide excellent support for the needs of the target market. In other words, they need companies with strong products or services and competitive prices that will attract customers to buy those products or services. Here are seven of the best life sciences tools and services stocks to buy Now in 2022:

BRKR

Bruker is a clinical diagnostics company serving the life sciences and healthcare industries. The company’s core products include mass spectrometry, biochemical analysis and data processing and analysis software. Bruker has experienced significant growth in the MS and HPLC segments, with the MS segment growing at an average rate of approximately 12% per year since 2011. The company has also made several strategic acquisitions to build its biochemical analysis tools and suite of software offerings. Bruker plans to grow both organically and through acquisitions, with a focus on expanding its presence in Asia. The company also plans to expand its portfolio of instruments, including adding new equipment for high-throughput sample preparation.

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories is a global leader in life sciences tools, services, and products. The company has a diverse range of products and services that serve a wide range of clients in the research, clinical and industrial fields. Bio-Rad’s core products and services include DNA and protein electrophoresis and chromatography systems, fluid handling automation systems, cell analysis, imaging systems, and a full range of services, including product development and analytical testing services. Bio-Rad has a long history of serving the life sciences industry and a track record of delivering consistent growth and profitability. The company has also expanded into new markets, and has successfully introduced new products and services to customers.

NeoGenomics (NEO)

NeoGenomics Laboratories is a clinical laboratory focused on oncology and genetic testing. The company’s core products and services include genetic testing, including cytogenetics and molecular testing. Molecular testing services. Nuclear imaging services. Cancer Immunotherapy NeoGenomics Laboratories is one of the largest and fastest growing cancer genetics laboratories in the United States, and the company’s growth can be attributed to several factors, including an expanding customer base, growth in genetic testing and immunotherapy, and an increased focus on increasing market share. Additionally, NeoGenomics plans to grow both organically and through acquisitions, with a focus on development in the greater New York City area. The company also has a strong set of opportunities available through its acquisition strategy, including labs and companies focused on genetic testing, immunotherapy and clinical research.

ICON plc (ICLR)

ICON plc is a supplier of clinical laboratory services, specialized analytical tests and a supplier of pathology services. The company’s primary products and services include clinical laboratory testing, including blood testing, molecular testing, and endoscopy. pathology services; and specialized analytical tests, including chemical analysis and microbiology. ICON is a global company, with over 50% of revenue coming from outside the UK, and the company has a broad client base, with more than 90% of its services being used for clinical testing. ICON has a proven track record of continuous growth and profitability. The company has also expanded into new markets and successfully brought new products and services to customers, including developing several offerings designed to meet the needs of smaller laboratories.

conclusion

The life sciences industry covers many areas, from diagnostics and research to health care services. With such a wide range of sub-sectors, you may be wondering which stocks can give you the best return on investment in the years to come. After all, some firms will perform better than others under different macroeconomic conditions. Therefore, investors should look for stocks that provide excellent support for the needs of the target market. In other words, they need companies with strong products or services and competitive prices that will attract customers to buy those products or services.

Leave a Comment